Functional Improvement with Hylan G-F 20 in Patients with Knee Osteoarthritis

Log in or subscribe to view full content.
Article is also available for purchase the article in one of the available formats.
Victoria A. Brander, MD and Teresa S. Stadler, MD

Table of Contents

Physician and Sportsmedicine:

Volume 37 No. 3

Category:

Clinical Features

Purchase this article in one of the formats specified below:

DOI: 10.3810/psm.2009.10.1728
Abstract: A systematic review of randomized, controlled, prospective clinical studies is described (8 trials; N = 1674 patients), with > 100 patients in each, which evaluated functional outcomes with hylan G-F 20 in secondary analyses. Hylan G-F 20 significantly improved Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) physical function versus appropriate/conventional care or corticosteroid, it significantly improved loss of activity versus saline, and it had similar functional improvements compared with progressive knee exercises or nonsteroidal anti-inflammatory drugs. Functional improvements with hylan G-F 20 also improved with pain relief. Hylan G-F 20 should be considered as part of a multimodal arthritis treatment regimen that focuses on improving function.

Keywords: function , hyaluronic acid , hylan , pain , WOMAC